Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Dosage for Cardiac Repair: Protocol Comparison

Rodent MI (Rutgers) 2–5mg 4 weeks Infarct size reduction 50% smaller infarct vs control Proof of mechanism. Timing-dependent protection Canine DCM (Veterinary) 5–7.5mg 8 weeks Exercise tolerance, NT-proBNP 34% improvement in 6-min walk distance Translational.

This comparison does not assign a generated winner or score.

  • Rodent MI (Rutgers)
  • 2–5mg
  • 4 weeks
  • Infarct size reduction
  • 50% smaller infarct vs control
  • Proof of mechanism. Timing-dependent protection
  • Canine DCM (Veterinary)
  • 5–7.5mg
  • 8 weeks
  • Exercise tolerance, NT-proBNP
  • 34% improvement in 6-min walk distance
  • Translational. Applicable to chronic heart failure models
  • Porcine MI (JACC)
  • 10mg
  • 6 weeks
  • Infarct expansion, ejection fraction
  • 38% reduction in adverse remodeling
  • Closest analog to human cardiac mass and physiology
  • Equine cardiac stress
  • 7.5mg
  • 12 weeks
  • Troponin levels, recovery time
  • 28% faster return to baseline cardiac biomarkers
  • Large animal data. Validates dosing in high-mass subjects
More references

Related material